Atlas Trials

A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies

Clinical trial NCT00732992 · COMPLETED

Trial details

NCT number
NCT00732992
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasm, Malignant
Start date
2008-08-01
Primary completion
2009-11-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.